Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study.
Yang TS, Chen HH, Bo-Wen L, Kim TW, Kim JG, Ahn JB, Lee MA, Lin J, Ho GF, Anh LT, Temraz S, Burge M, Chua C, Huang J, Park YS.
Yang TS, et al. Among authors: lin j.
Asia Pac J Clin Oncol. 2023 Dec;19(6):672-680. doi: 10.1111/ajco.13920. Epub 2023 Feb 28.
Asia Pac J Clin Oncol. 2023.
PMID: 36855017